Kardigan · 1 week ago
Vice President of Finance
Princeton, NJ
Full-time
Hybrid
Director/Executive
$315K/yr - $350K/yr
10+ years expKardigan is a heart health company focused on making cardiovascular disease preventable and curable. They are seeking a Vice President of Finance to lead the finance function and partner with R&D, clinical, and operational leadership, ensuring disciplined financial operations and strategic decision-making.
Artificial Intelligence (AI)BiopharmaHealth CareMedical
Responsibilities
Lead all FP&A activities, including annual budgeting, rolling forecasts, long-range planning, and scenario modeling
Develop sophisticated financial models to support program economics, clinical development planning, enrollment assumptions, and portfolio trade-offs
Establish a best-in-class, analytics-driven finance function that informs prioritization, capital allocation, and strategic decision-making
Drive disciplined, data-backed discussions around tradeoffs, risk, and return across programs and functions
Design and own executive-level reporting, dashboards, and performance metrics that enable faster, higher-quality decisions
Translate complex financial, clinical, and operational data into clear, actionable insights for executive leadership and program teams
Track performance versus plan and proactively identify opportunities to improve efficiency, outcomes, and capital effectiveness
Build and manage an integrated, portfolio-level financial view across development programs, platforms, and initiatives
Partner closely with R&D and program leadership to assess investment options, prioritization, and sequencing decisions
Serve as a strategic finance partner on capital deployment decisions, ensuring alignment with company objectives and long-term value creation
Play a key role in capital-raising efforts, including private financings and other strategic funding initiatives, through financial modeling, scenario analysis, diligence support, and investor materials
Support interactions with investors, bankers, and advisors by providing rigorous analytics and clear framing of financial and portfolio strategy
Act as a trusted finance partner to R&D, clinical, operations, legal, and people teams
Collaborate closely with Accounting, Legal, and external advisors to support financing processes, governance requirements, and transaction readiness
Support strategic initiatives, growth planning, and external-facing preparedness through rigorous analysis and clear communication
Partner with Accounting to ensure strong close processes, internal controls, and financial governance
Ensure financial systems, reporting tools, and ERP platforms (e.g., NetSuite) scale with the business and support advanced analytics
Contribute to building finance infrastructure appropriate for a late-stage, pre-commercial or commercializing biotech organization
Qualification
Required
Bachelor's degree in Finance, Accounting, Economics, or related field
10–15+ years of progressive experience in FP&A, strategic finance, and operational finance, including senior leadership roles
Significant experience in biotech or biopharma required; pharma, commercial, or launch-stage experience is a strong plus
Hands-on experience supporting capital raises (e.g., private financings, crossover rounds, or other strategic funding events), including modeling, diligence, and investor materials
Demonstrated ability to partner deeply with R&D and operational teams in a development-driven environment
Strong financial modeling and analytical skills, with a track record of influencing strategic decisions through data
Solid understanding of financial controls and enterprise financial operations
Experience working with and improving ERP and financial systems (e.g., NetSuite)
Executive-level communication skills, with the ability to balance detail, strategy, and speed in a complex, fast-moving environment
Judgment, curiosity, and leadership presence consistent with an executive on a long-term CFO development path
Company
Kardigan
Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.
51-200 employees
Funding
Current Stage
Growth StageTotal Funding
$554M2025-10-14Series B· $254M
2025-01-10Series A· $300M
Leadership Team
Brianne Jahn
Chief Financial Officer
Diane Hagerty
Chief Quality Officer
Recent News
2025-12-16
2025-11-19
Company data provided by crunchbase